Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: A fundamental cause of disease approach

被引:32
|
作者
Kim, Seijeoung [1 ]
Dolecek, Therese A. [2 ]
Davis, Faith G. [2 ]
机构
[1] Univ Illinois, Sch Publ Hlth, Div Hlth Policy & Adm, Chicago, IL 60612 USA
[2] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60612 USA
关键词
USA; Ovarian cancer; Stage at diagnosis; fundamental cause of disease; Survival; Mortality; Race; Ethnicity; SOCIOECONOMIC-STATUS; UNITED-STATES; LIFE-STYLE; SOCIAL EPIDEMIOLOGY; SOUTHWEST-ONCOLOGY; PROGNOSTIC-FACTORS; LUNG-CANCER; MORTALITY; RISK; DISPARITIES;
D O I
10.1016/j.socscimed.2010.03.033
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Associations between race, socioeconomic status (SES) and health outcomes have been well established. One of the ways in which race and SES affect health is by influencing one's access to resources, which confers ability to avoid or mitigate adverse outcomes. The fundamental cause of disease approach argues that when a new screening tool is introduced, individuals with greater resources tend to have better access to the innovation, thus benefiting from early detection and leading to better survival. Conversely, when there is no established screening tool, racial and SES differences in early detection may be less pronounced. Most ovarian cancer is diagnosed at advanced stages, because of the lack of an effective screening tool and few early symptoms. However, once detected, racial differences may still be observed in mortality and survival outcomes. We examined the racial differences in diagnosis and survival among ovarian cancer cases diagnosed during 1994-1998, in Cook County, Illinois (N = 351). There were no racial differences in the stage at diagnosis: 51.7% of white and 52.9% of black women were diagnosed at later stages (III and IV). Only age was associated with the stage at diagnosis. Tumor characteristics also did not differ between white and black women. Compared to white women, black women were less likely to be married, less educated, more frequently used genital powder, had tubal ligation, and resided in higher poverty census tracts. As of December 31, 2005, 44.3% of white and 54.5% of black women had died of ovarian cancer. Controlling for known confounding variables, the hazard ratio for ovarian cancer death between black and white women was 2.2. The findings show that fundamental cause perspective provides a potential framework to explore subtleties in racial disparities, with which broader social causes may be accounted for in explaining post diagnosis racial differences. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:274 / 281
页数:8
相关论文
共 50 条
  • [31] Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer
    Bristow, RE
    Montz, FJ
    Lagasse, LD
    Leuchter, RS
    Karlan, BY
    GYNECOLOGIC ONCOLOGY, 1999, 72 (03) : 278 - 287
  • [32] Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
    Yohann Dabi
    Cyrille Huchon
    Lobna Ouldamer
    Sofiane Bendifallah
    Pierre Collinet
    Alexandre Bricou
    Emile Daraï
    Marcos Ballester
    Vincent Lavoue
    Bassam Haddad
    Cyril Touboul
    Journal of Translational Medicine, 18
  • [33] PATIENTS WITH STAGE IV EPITHELIAL OVARIAN CANCER: UNDERSTANDING THE DETERMINANTS OF SURVIVAL
    Dabi, Y.
    Huchon, C.
    Ouldamer, L.
    Bendifallah, S.
    Collinet, P.
    Bricou, A.
    Darai, E.
    Ballester, M.
    Lavoue, V.
    Haddad, B.
    Touboul, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A453 - A454
  • [34] Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
    Dabi, Yohann
    Huchon, Cyrille
    Ouldamer, Lobna
    Bendifallah, Sofiane
    Collinet, Pierre
    Bricou, Alexandre
    Darai, Emile
    Ballester, Marcos
    Lavoue, Vincent
    Haddad, Bassam
    Touboul, Cyril
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [35] Racial Disparities in Cancer Stage at Diagnosis and Survival for Adolescents and Young Adults
    Taparra, Kekoa
    Kekumano, Kaeo
    Benavente, Ryan
    Roberto, Luke
    Gimmen, Megan
    Shontell, Ryan
    Cakobau, Henrietta
    Deo, Neha
    Kinslow, Connor J.
    Warner, Allison Betof
    Deville, Curtiland
    Shing, Jaimie Z.
    Vo, Jacqueline B.
    Patel, Manali I.
    Pollom, Erqi
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [36] Epithelial ovarian cancer:: Therapy of early-stage disease
    Meerpohl, HG
    Schröder, W
    Olbricht, S
    GYNAKOLOGE, 2001, 34 (11): : 1041 - 1049
  • [37] SEXUAL DIFFERENCES IN CANCER SURVIVAL - HORMONES OR STAGE AT DIAGNOSIS - REPLY
    ADAMI, HO
    KLARESKOG, L
    HOLMBERG, L
    PONTEN, J
    PERSSON, I
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (14): : 1810 - 1811
  • [38] Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
    Dilley, Sarah
    Erickson, Britt K.
    Phillips, Caroline E.
    Kennemer, Caroline R.
    Zhang, Bin
    Matin, Tasnia
    Martin, Jovana Y.
    Shah, Monjri S.
    Straughn, J. Michael, Jr.
    Leath, Charles A., III
    GYNECOLOGIC ONCOLOGY, 2018, 149 (01) : 49 - 52
  • [39] Estimating the contribution of epidemiologic risk factors to racial differences in epithelial ovarian cancer incidence
    Peres, Lauren C.
    Camacho, Tareq F.
    Bandera, Elisa V.
    Bethea, Traci N.
    Joslin, Charlotte E.
    Wu, Anna H.
    Beeghly-Fadiel, Alicia
    Cloyd, Emily K.
    Harris, Holly R.
    Moorman, Patricia G.
    Myers, Evan
    Ochs-Balcom, Heather M.
    Rosenow, Will L.
    Setiawan, Veronica W.
    Rosenberg, Lynn
    Schildkraut, Joellen M.
    CANCER RESEARCH, 2020, 80 (16)
  • [40] The effect of urban racial residential segregation on ovarian cancer diagnosis, treatment, and survival
    Laraja, Alexander
    Connor, Yamicia
    Poulson, Michael R.
    GYNECOLOGIC ONCOLOGY, 2024, 187 : 163 - 169